Navigation Links
AACC Pilot Studies Begin to Measure What Is Normal in Children's Development
Date:7/30/2013

HOUSTON, July 30, 2013 /PRNewswire/ -- AACC's Pediatric Reference Range Committee (PRRC) is performing two pilot studies to establish crucial pediatric reference intervals as part of the National Children's Study. Researchers speaking at AACC's 2013 Annual Meeting will discuss preliminary findings from these studies and underscore their importance to improving pediatric healthcare. Without solid numbers to interpret lab results, clinicians don't have a clear picture of age-appropriate biochemical indicators of normal childhood development.

(Logo: http://photos.prnewswire.com/prnh/20130701/PH41045LOGO )

Interpreting certain lab test results in children has been challenging due to the lack of pediatric reference intervals, which show the distribution of normal values in a diverse, healthy population. Hospitals have traditionally based reference ranges on values from hospitalized children, adjusted for outliers, and on small studies that have not yielded robust data. The AACC pilot studies will provide statistically reliable data that meets industry standards for establishing reference ranges.

"One of the problems that we've always had in children's hospitals is that you don't have healthy children in the hospital, so you can't comfortably use that data," said AACC PRRC chair and session moderator, Michael Bennett, PhD, FRCPath, director of the Michael J. Palmieri Metabolic Laboratory at Children's Hospital of Philadelphia and professor of pathology and laboratory medicine at the University of Pennsylvania School of Medicine. "With a large cohort of healthy children from across the country, the National Children's Study offers laboratorians a unique opportunity to develop good reference ranges and also to understand better how the biomarkers that we measure in our labs reflect normal childhood development."

Bennett will be joined by the studies' principal investigators. Dr. Patricia Jones, clinical director of the chemistry and metabolic disease labs at Children's Medical Center of Dallas and professor of pathology and medical laboratory science at UT Southwestern Medical Center, has been investigating reference intervals for four steroid hormones, 17-hydroxy-progesterone, androstenedione, testosterone, dehydroepiandrosterone (DHEA) and DHEA–sulfate. Imbalances in these hormones can cause congenital adrenal hyperplasia, which affects development of sexual characteristics in children and in severe forms leads to life-threatening sodium insufficiency. "This is one of those areas where reference intervals, particularly in the first months of life, are very, very important, yet we just don't have a lot of information from normal children because it's so difficult to get samples from newborns," said Jones.

Dr. Dennis Dietzen, medical director of the core laboratory at St. Louis Children's Hospital and an associate professor of pediatrics at the Washington University School of Medicine in St. Louis, is developing reference ranges for 35 amino acids, which play a key role in physical and cognitive development. "Our work with the National Children's Study will enable us to measure not only variation occurring between children over time but also within the same child. This will help detect subtle but important changes in some amino acids in each pediatric patient, leading to much better monitoring of development and improved detection and treatment of abnormalities," said Dietzen.

Press Briefing

AACC Annual Meeting registration is free for members of the media. Reporters can register online here: https://www.xpressreg.net/register/AACC073/media/landing.asp.

AACC's Pediatric Reference Range Pilot Studies: Measuring Childhood Development.
Tuesday, July 30
11 a.m. – 12 p.m.
George R. Brown Convention Center
Room 322B
Houston, Texas

About AACC Annual Meeting & Clinical Lab Expo
AACC's Annual Meeting offers 5 days packed with opportunities to learn about exciting science. Plenary sessions feature expert presentations on hot topics such as the role of insulin in obesity, the function of "junk" DNA in human development, the controversy over vitamin D intake recommendations, patient-based therapeutics discovery, and the impact of microbial symbionts on human health.

At the 2013 AACC Clinical Lab Expo, more than 625 exhibitors will fill the show floor of the George R. Brown Convention Center with displays of the latest diagnostic technology, including but not limited to automation, information systems, point-of-care, and biotech.

About AACC
Dedicated to achieving better health through laboratory medicine, the American Association for Clinical Chemistry (AACC) brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

Molly Polen
AACC
Director of Communications & PR
(p) 202.420.7612
(c) 703.598.0472
mpolen@aacc.org


'/>"/>
SOURCE AACC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Major Diabetes Peer-Review Journal Publishes Postive Results Of Ultradian Diagnostics Human Pilot Study
2. Addressing Scientific and Regulatory Challenges for Abuse Liability Studies, New Life Science Webinar Hosted by Xtalks
3. PointCross Life Sciences Opens New Office in Silver Spring, Maryland for Data Standardization of Nonclinical Studies
4. Practical Uses for Flow Cytometry in Toxicology Studies Within a Glp Environment, New Life Science Webinar Hosted by Xtalks
5. Best Practices for Conducting Extractable and Leachable Studies, new life sciences webinar hosted by Xtalks
6. Drink to Your (Oral) Health: Atlanta Dentist Looks at Two Recent Studies Exploring Green Tea’s Effects on Oral Health
7. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
8. Going a step Further: Phase IV and Post-Marketing Observational Studies add Value to new Therapies, life Science Webinar Hosted by Xtalks
9. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
10. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
11. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):